Topics

Articles

UK cell and gene therapy location expected to be cGMP-ready by mid-2022

Will help biomed startups in furthering oncology R&D

There are currently 100,000 doses standing by

$180M collaboration aims to introduce multiple vaccine candidates in 2022

Two-dose COVAXIN currently under EUA in India

CDMO to take over operations, including equipment and workforce, at site in Couvet, Switzerland

Deal completes Verista's lifecycle support for pharma, which now includes consulting, technology and manufacturing

Agreement provides Acentrus with specialty pharmacy accreditation

In Phase III at the moment, mRNA dose will be produced at Bayer's Wuppertal, Germany facility

Production expected to begin in the second quarter